Accountability and
Liability for Individuals
and Organizations
Alona Cables, Antonio Baisey, Kelsey Angelini, Lakeya Randle,
Lakrisha West Clarissa Cruz
University of Phoenix
HCS/430: Legal Issues In Health Care: Regulation And Compliance
Taryn Zubich
July 4, 2022
Presentation Cover
Option 2
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
Contoso
Pharmaceuticals
page 2
• Lorem ipsum dolor sit amet, consectetur
adipiscing elit.
• Ut fermentum a magna ut eleifend. Integer
convallis suscipit ante eu varius.
• Morbi a purus dolor. Suspendisse sit amet
ipsum finibus justo viverra blandit.
• Ut congue quis tortor eget sodales.
About Us
Lorem ipsum dolor sit amet,
consectetur adipiscing elit. Etiam
aliquet eu mi quis lacinia. Ut fermentum
a magna ut.
Contoso
Pharmaceuticals
page 3
The Problem
Declining Market
Financial
Trust
Cost
Margins
Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
Etiam aliquet eu mi
quis lacinia. Ut
fermentum a magna
ut eleifend.
Integer convallis
suscipit ante eu
varius. Morbi a purus
dolor.
Suspendisse sit amet
ipsum varius finibus
justo viverra blandit.
Ut congue quis tortor
varius eget sodales.
Contoso
Pharmaceuticals
page 4
Prioritize
Authorize
Monetize
Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
Etiam aliquet eu mi
quis lacinia.
Integer convallis
suscipit ante eu
varius.
Solution
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
Etiam aliquet eu mi quis.
Contoso
Pharmaceuticals
page 5
Unique
First to Market
Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
Etiam aliquet eu mi.
Ut fermentum a
magna ut eleifend.
Product
Tested
Authentic
Integer convallis
suscipit eu varius.
Morbi a purus dolor.
Suspendisse sit amet
ipsum varius finibus
justo viverra blandit.
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
Etiam aliquet eu mi quis.
Contoso
Pharmaceuticals
page 6
Emphasize your
main benefit
Other benefits include
• Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
• Nunc tempus, risus sodales hendrerit,
arcu dolor commodo libero.
Contoso
Pharmaceuticals
page 7
Section Divider
Lorem ipsum dolor sit amet,
consectetur adipiscing elit
Contoso
Pharmaceuticals
page 8
Business Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Research
Finance
Invest
Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
Etiam aliquet eu mi
quis lacinia. Ut
fermentum a magna
ut eleifend.
Integer convallis
suscipit ante eu
varius. Morbi a purus
dolor.
Contoso
Pharmaceuticals
page 9
Market Opportunity Option 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
$1B
$2B
• Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
• Ut congue quis tortor eget
sodales. Nulla a erat eget
nunc hendrerit ultrices eu nec
nulla.
• Etiam aliquet eu mi quis
lacinia. Ut fermentum a
magna ut eleifend. Integer
convallis suscipit ante eu
varius.
• Morbi a purus dolor.
Suspendisse sit amet ipsum
finibus justo viverra blandit.
• Donec viverra leo aliquet,
auctor quam id, convallis orci.
Contoso
Pharmaceuticals
page 10
Market Opportunity Option 2
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
$3B
$2B
$1B
Opportunity to Build
Freedom to Invent
Few Competitors
Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
Etiam aliquet eu mi quis
lacinia. Ut fermentum a
magna ut eleifend.
Integer convallis suscipit
ante eu varius. Morbi a
purus dolor.
Contoso
Pharmaceuticals
page 11
Competition Option 1
Contoso Pharmaceuticals
Competitor
• Nulla a erat eget nunc hendrerit ultrices eu nec
nulla. Donec viverra leo aliquet, auctor quam id,
convallis orci.
• Praesent venenatis quam tortor, id viverra nunc
rutrum a.
•
•
Sed in molestie est. Cras ornare turpis at ligula
posuere, sit amet accumsan neque lobortis.
Maecenas mattis risus ligula, sed ullamcorper nunc
efficitur sed.
•
•
Maecenas malesuada ultricies sapien sit amet
pharetra.
Nunc tempus, risus sodales hendrerit, arcu dolor
commodo libero, a sollicitudin quam nulla quis
lectus. In at porta mauris.
Contoso
Pharmaceuticals
page 12
Competition Option 2
Convenience
Contoso
Pharmaceuticals
Expensive
Affordable
Inconvenient
Contoso
Pharmaceuticals
page 13
Growth Strategy
How will we scale in the future
Phase 1
Phase 2
Phase 3
Month, Year
Month, Year
Month, Year
• Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
• Etiam aliquet eu mi quis
lacinia. Ut fermentum a
magna ut eleifend.
Integer convallis suscipit
ante eu varius.
• Morbi a purus dolor.
Suspendisse sit amet
ipsum finibus justo
viverra blandit.
• Ut congue quis tortor
eget sodales. Nulla a erat
eget nunc hendrerit
ultrices eu nec nulla.
• Donec viverra leo
aliquet, auctor quam id,
convallis orci.
• Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
Contoso
Pharmaceuticals
page 14
Traction
Forecasting for success
Vendors
Users
Gross Revenue
Gross
Revenue
Company
Revenue
$300,000
20YY
0
0
$0
$0
$250,000
20YY
10
100
$6,750
$1,013
$200,000
$150,000
20YY
50
500
$33,750
$5,063
$100,000
20YY
200
2000
$135,000
$20,250
20YY
400
4000
$270,000
$40,500
$50,000
$0
1
2
3
4
5
Contoso
Pharmaceuticals
page 15
Timeline
Our two-year action plan
AUG
Trials
Marketing
Launch
Month, 20YY
Month, 20YY
Month, 20YY
SEP
OCT
NOV
DEC
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
20YY
OCT
NOV
DEC
JAN
FEB
MAR
APR
MAY
20YY
Legislation
Investment
Procurement
Month, 20YY
Month, 20YY
Month, 20YY
Contoso
Pharmaceuticals
page 16
Financials
Year 1
Year 2
Year 3
Detailers
5,000
40,000
160,000
Users
50,000
400,000
1 600,000
Sales
500,000
4 000,000
16 000,000
75
80
90
5 625,000
48 000,000
216 000,000
0
0
0
5 625,000
48 000,000
216 000,000
• Sales & Marketing
5 062,500
38 400,000
151 200,000
70%
• Customer Service
1 687,500
9 600,000
21 600,000
10%
• Product
Development
562,500
2 400,000
10 800,000
5%
• Research
281,250
2 400,000
4 320,000
2%
7 593,750
52 800,000
187 920,000
-1 968,750
-4 800,000
28 080,000
Average Price per Sale
Revenue @ 15%
• Cost of Revenue
Gross Profit
Expenses
Total Expenses
EBIT
Contoso
13%
Pharmaceuticals
page 17
Team
Mirjam Nils
Victoria Lindqvist
Angelica Astrom
COO
COB
CFO
Lorem ipsum dolor sit amet,
consectetur adipiscing elit. Etiam
aliquet eu mi quis lacinia. Ut
fermentum a magna ut eleifend.
Integer convallis suscipit ante eu
varius.
Morbi a purus dolor. Suspendisse sit
amet ipsum finibus justo viverra
blandit. Ut congue quis tortor eget
sodales. Nulla a erat eget nunc
hendrerit ultrices eu nec nulla.
Donec viverra leo aliquet, auctor quam
id, convallis orci. Sed in molestie est.
Cras ornare turpis at ligula posuere, sit
amet accumsan neque lobortis.
Contoso
Pharmaceuticals
page 18
Team Alternate
Mirjam
Nilsson
Victoria
Lindqvist
Alexander
Martensson
COO
COB
CFO
Angelica
Astrom
Mira
Karlsson
Flora
Berggren
Head of Operations
Head of Technical
Creative Director
Contoso
Pharmaceuticals
page 19
Funding
Fund Category
Fund Category
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
$14,000
$32,000
Fund Category
. Integer convallis suscipit ante eu
varius. Morbi a purus dolor.
$12,000
Etiam aliquet eu mi quis lacinia.
Ut fermentum a magna ut.
$82,000
Fund Category
Suspendisse sit amet ipsum finibus
justo viverra blandit. Ut congue quis
tortor eget sodales.
Contoso
Pharmaceuticals
page 20
• Lorem ipsum dolor sit amet, consectetur
adipiscing elit. Etiam aliquet eu mi quis
lacinia.
Summary
• Ut fermentum a magna ut eleifend. Integer
convallis suscipit ante eu varius. Morbi a
purus dolor. Suspendisse sit amet ipsum
finibus justo viverra blandit.
Summary tagline or
sub-headline
• Ut congue quis tortor eget sodales. Nulla a
erat eget nunc hendrerit ultrices eu.
Contoso
Pharmaceuticals
page 21
Thank You
April Hansson
+1 23 987 6554
[email protected]
www.contoso.com
Contoso
Pharmaceuticals
page 22
References:
*
Contoso
Pharmaceuticals
page 23

Purchase answer to see full
attachment